Taken together, these results demonstrate that wild-type RBM10, but not RBM10-I316F, can inhibit c-Myc expression and activity, consequently suppressing the proliferation and growth of lung cancer cell and tumorigenesis. The gene discussed is MYC; the disease is lung carcinoma.